Increased concentration of hepatocyte growth factor in the sera of patients with gastrointestinal cancer

Oncology Reports

Volumn 4, Issue 6, 1997, Pages 1239-1241

  Narita, Tatsuhiko ^a   Mitsuoka, Chikako ^a   Kimura, Naoko ^a   Toi, Masakazu ^b   Nakashio, Tatsuaki ^c   Sekiguchi, Kiyoshi ^d   Iwanari, Hiroko ^d   Kannagi, Reiji ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Institute of Immunology   (Japan)

Author keywords

Gastrointestinal cancer; Hepatocyte growth factor; Tumor marker

Indexed keywords

SCATTER FACTOR;

ARTICLE; COLORECTAL CANCER; DIAGNOSTIC VALUE; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; STOMACH BIOPSY; STOMACH CANCER;

EID: 0030883867     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.4.6.1239     Document Type: Article

References (19)

1. Nakamura T, Nishizawa T, Hagata M, Seki T, Shimonishi M, Sugimura A, Tashiro K and Shimizu S: Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443, 1989.
2. Matsumoto K and Nakamura T: Hepatocyte growth factor; molecular structure, roles in liver regeneration, and other biological functions. Crit Rev Oncogen 3: 27-54, 1992.
3. Kawakami-Kimura N, Narita T, Ohmori K, Yoneda T, Matsumoto K, Nakamura T and Kannagi R: Involvement of hepatocyte growth factor in increased integrin expression on HepG2 cells triggered by adhesion to endothelial cells. Br J Cancer 75: 47-53, 1997.
4. Yamashita J, Ogawa M, Yamashita S, Nomura K, Kuramoto M, Saishoji T and Shin S: Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 54: 1630-1633, 1994.
5. Tempest PR, Stratton MR and Cooper C: Structure of the met protein and variation of met protein kinase activity among human tumor cell lines. Br J Cancer 58: 3-7, 1988.
6. Di Renzo MF, Narsimhan RP, Olivero M, Bretti S, Giorano S, Medico E, Gaglia P, Zara P and Compglio PM: Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 6: 1997-2003, 1991.
7. Tajima H, Matsumoto K and Nakamura T: Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species. Exp Cell Res 202: 423-431, 1992.
8. Takanami I, Tanaka F, Hashizume T, Kikuchi K, Yamamoto Y, Yamamoto T and Kodaira S: Hepatocyte growth factor and c-met/hepatocyte growth factor receptor in pulmonary adenocarcinomas; an evaluation of their expression as prognostic markers. Oncology 53: 392-397, 1996.
9. Ichimura E, Maeshima A, Nakajima T and Nakamura T: Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance. Jpn J Cancer Res 87: 1063-1069, 1996.
10. Tsubouchi H, Nitani Y, Hirano S, Nakayama H, Gohda E, Arakaki N, Sakiyama K, Kimoto M and Kawakami S: Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 13: 1-5, 1991.
11. Tomoaki T, Nagoshi S and Fujiwara K: Significance of serum human hepatocyte growth factor levels in patients with hepatic failure. Hepatology 15: 1-4, 1992.
12. Taniguchi T, Toi M, Inada K, Imazawa T, Yamamoto Y and Tominaga T: Serum concentrations of hepatocyte growth factor in breast cancer patients. Clin Cancer Res 1: 1031-1034, 1995.
13. Taniguchi T, Kitamura M, Arai K, Iwasaki Y, Yamamoto Y, Igari A and Toi M: Increase in the circulating level of hepatocyte growth factor in gastric cancer patients. Br J Cancer 75: 673-677, 1997.
14. Matsumoto K, Date K, Ohmichi H and Nakamura T: Hepatocyte growth factor in lung morphogenesis and tumor invasion; role as a mediator in epithelium-mesenchyme and tumor-stroma interactions. Cancer Chemother Pharmacol 38: 42-47, 1996.
15. Iwazawa T, Shiozaki H, Doki Y, Inoue M, Tamura S, Matsui S, Monden T, Matsumoto K, Nakamura T and Monden M: Primary human fibroblasts induce diverse tumor invasiveness; involvement of HGF as an important paracrine factor. Jpn J Cancer Res 87: 1134-1142, 1996.
16. Matsumoto K, Data K, Shimura H and Nakamura T: Acquisition of invasive phenotype in gallbladder cancer cells via mutual interaction of stromal fibroblasts and cancer cells as mediated by hepatocyte growth factor. Jpn J Cancer Res 87: 702-710, 1996.
17. Furukawa T, Duguid WP, Kobari M, Matsuno S and Tsad MS: Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis. Am J Pathol 147: 889-895, 1995.
18. Tuck AB, Park M, Sterns EE, Boag A and Elliott BE: Co-expression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am J Pathol 148: 225-232, 1996.
19. Inoue T, Chung Y-S, Yashiro M, Nishimura S, Hasuma T, Otani S and Sowa M: transforming growth factor-β and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells. Jpn J Cancer Res 88: 152-159, 1997.